US pharmacy chain Walgreens has agreed to pay US$595 million to a telemedicine group to settle a dispute over covid-19 testing.
26 February 2025
Danish pharmaceutical group Novo Nordisk is preparing to launch an ICC arbitration worth US$830 million against a Singapore biosciences company for alleged fraud, after acquiring a hypertension drug that failed in clinical trials.
19 February 2025
A US court has refused to set aside an award ordering US pharmacy chain Walgreens to pay US$988 million in a dispute over covid-19 testing, rejecting allegations the sole arbitrator was biased and ignored a liability cap.
13 February 2025
A Pittsburgh-based health and wellness retailer has won ICDR awards worth over US$53 million against its franchisees in Singapore and the Philippines, which it is trying to enforce in the US courts.
04 October 2024
A court in Illinois has largely confirmed an ICC award worth US$115 million in favour of a US telemedicine company against the sellers of an Indian healthcare business – while overturning its findings against a prominent Keralan businessman.
30 September 2024
A UK court has dismissed the Czech Republic’s remaining challenges to a US$750 million treaty award won by investors in a blood plasma business, having previously upheld one ground raised by the state.
09 August 2024
A Mumbai healthcare provider has discontinued an ad hoc arbitration in which it had sought to block the sale of a hospital network to a rival US bidder – after failing to secure interim relief.
20 May 2024
AstraZeneca has applied to a German court to set aside a US$46.4 million German Arbitration Institute (DIS) award over milestone payments for its purchase of a cancer diagnostics start-up.
26 April 2024
US pharmacy chain Walgreens has challenged a US$988 million award in a dispute over covid-19 testing – alleging the sole arbitrator exceeded his authority and was biased because of a “devastating family tragedy”.
27 March 2024
A US digital health services provider has won an ICC award worth over US$110 million against the sellers of an Indian healthcare business over their refusal to relinquish control of the company after the sale.
26 March 2024
Unlock unlimited access to all Global Arbitration Review content